Perioperative Anticoagulation Management for Patients with Renal Impairment Undergoing Debridement

Preoperative Anticoagulation Discontinuation

The American College of Chest Physicians recommends stopping unfractionated heparin (UFH) infusion 4-6 hours before surgery to completely eliminate anticoagulant effect, regardless of renal function status 1, 2
UFH has a dose-dependent elimination half-life of 90 minutes (range 30-120 minutes), making the 4-6 hour timeframe sufficient for clearance 1, 2
UFH is the preferred bridging anticoagulant in patients with severe renal insufficiency (CrCl <30 mL/min) because it does not accumulate in renal failure 1, 3

Delay UFH restart for at least 24 hours postoperatively due to moderate-to-high bleeding risk 2, 3
Resume UFH without a bolus dose at the same infusion rate used preoperatively when adequate hemostasis is confirmed (minimal wound drainage, stable hemoglobin) 1, 2
Consider prophylactic-dose UFH initially if hemostasis is questionable, then advance to therapeutic dosing after 24-48 hours 3

Low molecular weight heparins (LMWH) should be avoided in severe renal impairment due to risk of accumulation and bleeding 1, 3
Do not use LMWH in patients with CrCl <30 mL/min, as this is the primary indication for choosing UFH over LMWH 1, 3
Do not restart therapeutic-dose heparin too early postoperatively, as premature resumption is the primary driver of major bleeding complications after surgery 3